Search filters

List of works by Nezam Afdhal

A Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Hepatitis C Virus Genotype 1

scientific article published on December 2014

A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease

article

A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care

scientific article

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results.

scientific article published in September 2009

A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C ⬇️

scientific article published on May 1, 2012

A recombinant bovine gallbladder mucin polypeptide binds biliary lipids and accelerates cholesterol crystal appearance time

scientific article published on 01 April 1999

A solid-state NMR study of phospholipid-cholesterol interactions: sphingomyelin-cholesterol binary systems

scientific article

Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study

scientific article published on 18 December 2014

An unusual cause of abdominal pain in a patient with hepatitis C cirrhosis.

scientific article published in April 2005

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial ⬇️

scientific article published on February 11, 2013

Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks.

scientific article

Antiviral Therapy for Treatment Naïve Patients with Hepatitis C Virus

scientific article published on 01 March 2006

Antiviral therapy for treatment naïve patients with hepatitis C virus

scientific article published in September 2004

Aspirin use is associated with lower indices of liver fibrosis among adults in the United States.

scientific article published on 7 January 2016

Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.

scientific article published on April 2009

Assessment of liver fibrosis in co-infected patients

scientific article

Atomic force microscopy reveals aggregation of gastric mucin at low pH.

scientific article

Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection

scientific article published on 10 March 2018

Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C.

scientific article

Biopsy no more; changing the screening and diagnostic algorithm for hepatitis C.

scientific article published on 20 December 2012

Biopsy or Biomarkers: Is There a Gold Standard for Diagnosis of Liver Fibrosis?

scientific article published on 01 August 2004

Can serum markers be used to reliably detect liver fibrosis?

scientific article published on 01 March 2005

Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C.

scientific article published on 9 November 2010

Cholangiocarcinoma of the hepatic hilum (Klatskin tumor)

scientific article published on 01 April 2002

Chronic hepatitis B: integrating long-term treatment data and strategies to improve outcomes in clinical practice

scientific article

Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma

scientific article published on 01 April 2011

Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

scientific article

Clinical decisions. Management of incidental hepatitis C virus infection

scientific article published on April 2009

Clinical utility of interleukin-28B testing in patients with genotype 1.

scientific article published on July 2012

Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

scientific article published on July 2004

Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis

scientific article published on September 2010

Contemporary assessment of hepatic fibrosis

scientific article

Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.

scientific article

Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography

scientific article published on 25 August 2015

Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score

scientific article

Crohnʼs and Stones

scientific article published on 01 May 1999

DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis

scientific article published on 25 January 2018

Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests? ⬇️

scientific article published on May 1, 2003

Diagnosis and quantitation of fibrosis

scientific article

Diagnosis of liver fibrosis in 2008 and beyond.

scientific article published on September 2008

Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.

scientific article published on 24 August 2011

Diffusion behavior of lipid vesicles in entangled polymer solutions.

scientific article

Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis

scientific article published on 30 December 2015

Direct costs of first-generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection

scientific article published on 25 May 2015

Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis.

scientific article published in January 2006

Duration of peginterferon therapy in acute hepatitis C: a randomized trial

scientific article published in May 2006

EUS-guided liver biopsy: a procedure looking for an indication

scientific article published on 01 March 2009

Early TIPS to Improve Survival in Acute Variceal Bleeding

scientific article published on 01 June 2010

Effect of Registries and Cohort Studies on HCV Treatment

scientific article published on 25 July 2016

Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial

scientific article published on July 2012

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.

scientific article published on 10 March 2017

Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients.

scientific article published on 10 July 2017

Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A Randomized Trial ⬇️

scientific article published on August 4, 2013

Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition

scientific article published on 23 October 2011

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia

scientific article

Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

scientific article

Eltrombopag in patients with chronic liver disease ⬇️

scientific article published on March 4, 2013

Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy

scientific article

Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy

scientific article published in December 2004

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study

scientific article

Erratum: Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration-Controlled Transient Elastography.

scientific article

Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones

scientific article published in July 2004

Evaluation of liver fibrosis: a concise review

scientific article published on June 2004

Evaluation of liver lesions

scientific article published on May 2012

Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study

scientific article

Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.

scientific article published on 24 January 2007

Evidence That Gallbladder Epithelial Mucin Enhances Cholesterol Cholelithogenesis in MUC1 Transgenic Mice

article

Exceeding the limits of liver histology markers

scientific article published on 18 October 2008

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

scientific article published on 12 February 2017

Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system

scientific article published on 01 July 1996

FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice

scientific article

FibroScan in the Diagnosis of Hepatitis C Virus Infection

scientific article published on August 2013

Fibroscan (transient elastography) for the measurement of liver fibrosis

scientific article

Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.

scientific article published on 26 March 2016

Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group

scientific article published on 18 September 2006

Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

scientific article published on March 2007

Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes

scientific article published on April 2004

Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients

scientific article

Health Care Quality Measurement in the Care of Patients With Cirrhosis

article

Helicobacter pylori moves through mucus by reducing mucin viscoelasticity

scientific article

Hemodynamic effects of substance P and its receptor antagonist RP67580 in anesthetized rats with carbon tetrachloride-induced cirrhosis

scientific journal article

Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.

scientific article published on August 2004

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

scientific article published in March 2005

Hepatitis C pharmacogenetics: state of the art in 2010.

scientific article published on January 2011

Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate

scientific article published on 16 August 2010

Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis

scientific article

Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.

scientific article

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

scientific article

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir

scientific article

Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.

scientific article published on December 2003

Interaction of mucin with cholesterol enriched vesicles: role of mucin structural domains

scientific article published in March 2004

Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response

scientific article

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

scientific article

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

scientific article

Introduction: thrombocytopenia in chronic liver disease -- treatment implications and novel approaches.

scientific article

Iron, HCV, and liver cancer: hard metal setting the pace?

scientific article

Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3.

scientific article published on October 2013

Lack of the intestinal Muc1 mucin impairs cholesterol uptake and absorption but not fatty acid uptake in Muc1-/- mice

scientific article published on 8 April 2004

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

scientific article published on 15 May 2015

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

scientific article published on 9 May 2015

Letter: would aspirin alleviate fibrosis in alcoholic liver disease? Authors’ reply

scientific article published on 01 July 2016

Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection

scientific article

Lith genes and genetic analysis of cholesterol gallstone formation

scientific article published on June 2010

Liver cirrhosis

scientific article

Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors

scientific article published on January 2003

Liver masses and eosinophilia

scientific article published in January 2008

Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.

scientific article published on February 1998

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

scientific article

Longitudinal Correlations Between MRE, MRI-PDFF, and Liver Histology in Patients with Nonalcoholic Steatohepatitis: Analysis of Data from a Phase 2 Trial of Selonsertib

article

Low likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental status

scientific article published on 4 June 2014

Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States.

scientific article published on 27 April 2015

Maintenance therapy for chronic hepatitis C.

scientific article

Management of hepatitis C virus in special populations: patient and treatment considerations

scientific article

Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?

scientific article published in August 2012

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

scientific article published in December 2009

Methasteron-Associated Cholestatic Liver Injury: Clinicopathologic Findings in 5 Cases

scientific article published on 09 January 2008

Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection

scientific article published in October 2006

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C

scientific article published on 24 August 2011

Neurologic Manifestations of Hepatitis C Virus Infection

scientific article

Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy

scientific article

Noninvasive Markers of Liver Fibrosis

scientific article published on June 2006

Noninvasive assessment of liver fibrosis

scientific article

On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial

scientific article

Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.

scientific article published in August 2007

Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice

scientific article published on 27 December 2005

Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response

scientific article published on 01 March 2006

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial

scientific article published in October 2007

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

scientific article published in August 2006

Performance of an Optimized Paper-Based Test for Rapid Visual Measurement of Alanine Aminotransferase (ALT) in Fingerstick and Venipuncture Samples

scientific article published on 28 May 2015

Perspectives on fibrosis progression in hepatitis C: an à la carte approach to risk factors and staging of fibrosis

scientific article published on January 2010

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus

scientific article published in November 2007

Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH

scientific article published on 13 October 2015

Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir

scientific article

Potentially curative treatment in patients with hepatocellular cancer-results from the liver cancer research network

scientific article published on 07 June 2012

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

scientific article published on 25 April 2005

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

scientific article published on 10 June 2016

Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis

scientific article published on April 2007

Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis

scientific article published on 01 April 2006

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

scientific article published on April 2006

Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response

scientific article

Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

scientific article published in January 2007

Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults

scientific article published on October 2007

Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C

scientific article published on 4 November 2011

Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study

scientific article

Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network

scientific article published on 17 April 2018

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

scientific article

Reply

scientific article published on 27 May 2014

Response-guided telaprevir combination treatment for hepatitis C virus infection

scientific article

Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection.

scientific article

Rheology of Gastric Mucin Exhibits a pH-Dependent Sol−Gel Transition

scientific article published on 03 April 2007

Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.

scientific article published on 20 July 2016

Role of epoetin alfa in maintaining ribavirin dose

scientific article

SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants.

scientific article

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

scientific article

Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older

scientific article published on 24 December 2015

Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

scientific article published on June 2015

Serum Activity of Macrophage-Derived Adenosine Deaminase 2 Is Associated With Liver Fibrosis in Nonalcoholic Fatty Liver Disease

scientific article published on 20 November 2017

Serum Ammonia in Associated With Transplant-free Survival in Hospitalized Patients With Acutely Decompensated Cirrhosis

scientific article published on 12 November 2015

Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience

scientific article published on 5 June 2013

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease

scientific article

Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C

scientific article

Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease

scientific article

Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

article

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease

Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1.

scientific article published on 23 October 2011

Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus

scientific article published on 12 February 2018

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

scientific article

Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study

scientific article published on 28 September 2014

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

scientific article

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

scientific article published on 15 March 2013

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies

scientific article published on 9 February 2018

Stability of liver fibrosis among HCV-infected injection drug users

scientific article published on 15 March 2012

Staging Liver Fibrosis in Hepatitis C: A Challenge for This Decade

scientific article published on 01 December 2011

Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease

scientific article published on 27 January 2016

Stiffness and Impedance: The New Liver Biomarkers

scientific article published on 01 October 2007

Symptomatic focal nodular hyperplasia during pregnancy: a case report

scientific article published on 01 January 2004

Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation

scientific article

Technology evaluation: A critical step in the clinical utilization of novel diagnostic tests for liver fibrosis

scientific article published on 29 January 2007

Telaprevir for previously treated chronic HCV infection

scientific article

The ASK1 Inhibitor Selonsertib in Patients with Nonalcoholic Steatohepatitis: A Randomized, Phase 2 Trial

scientific article published on 11 September 2017

The Amino-Terminal Sequence of MUC5B Contains Conserved Multifunctional D Domains: Implications for Tissue-Specific Mucin Functions ⬇️

scientific article published on October 9, 1998

The Clinical Outcome of Small (<20 mm) Arterially Enhancing Nodules on MRI in the Cirrhotic Liver

scientific article published on 23 May 2007

The Conundrum of Cryptogenic Cirrhosis: Adverse Outcomes without Treatment Options

scientific article published on 23 August 2018

The Impact of Individual Patient Data in a Network Meta Analysis: An investigation into parameter estimation and model selection

scientific article published on 15 August 2018

The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis

scientific article published on 4 August 2016

The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease

scientific article published on 15 March 2016

The acute and long-term effect of balloon sphincteroplasty on papillary structure in pigs.

scientific article

The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection

scientific article

The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis

scientific article published on July 2010

The clinical significance of persistently normal ALT in chronic hepatitis B infection

scientific article published on 24 September 2007

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease

scientific article published in April 2009

The natural history of hepatitis C.

scientific article published in January 2004

The not so good effects of nitric oxide inhibition with methylene blue in cirrhosis and ascites.

scientific article published on 17 February 2007

The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific

scientific article published on 07 October 2010

The pronase resistance of cholesterol-nucleating glycoproteins in human bile

scientific article published on 01 June 1996

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis – a pilot study ⬇️

scientific article published on November 30, 2011

Therapeutic strategies for chronic hepatitis B virus infection in 2008.

scientific article published in December 2008

Thrombocytopenia associated with chronic liver disease

scientific article

Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.

scientific article published on 23 October 2011

Transient elastography for predicting clinical outcomes in patients with chronic liver disease ⬇️

scientific article published on July 1, 2011

Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.

scientific article

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

scientific article published on 18 March 2015

Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease

scientific article

Ultrasound-based hepatic elastography: origins, limitations, and applications

scientific article published on October 2010

Urinary assays for desmosine and hydroxylysylpyridinoline in the detection of cirrhosis

scientific article published on 01 December 1997

Use of growth factors with antiviral therapy for chronic hepatitis C.

scientific article

Utilization of FibroScan in clinical practice

scientific article published on February 2014

Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States

scientific article published in June 2009

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction

scientific article

Vibration-controlled transient elastography: a practical approach to the noninvasive assessment of liver fibrosis

scientific article

Viscoelastic properties and dynamics of porcine gastric mucin

scientific article

Watchful waiting: role of disease progression on uncertainty and depressive symptoms in patients with chronic hepatitis C

scientific article

Welcome to the new, all electronic Journal of Viral Hepatitis.

scientific article published in January 2015

Xenogeneic Transplantation of Porcine Hepatocytes into the CCl4 Cirrhotic Rat Model

scientific article published on 01 November 1999

Paulina is supported by:

About Paulina

Help